Single Enantiomer Versus Racemate: Chiral Distinction in the Proton Pump Inhibitors Omeprazole and Esomeprazole. Issue 4 (12th March 2014)
- Record Type:
- Journal Article
- Title:
- Single Enantiomer Versus Racemate: Chiral Distinction in the Proton Pump Inhibitors Omeprazole and Esomeprazole. Issue 4 (12th March 2014)
- Main Title:
- Single Enantiomer Versus Racemate: Chiral Distinction in the Proton Pump Inhibitors Omeprazole and Esomeprazole
- Authors:
- Marom, Hili
Pogodin, Sergey
Agranat, Israel - Abstract:
- <abstract abstract-type="main"> <title>ABSTRACT</title> <p>Chiral distinction in the proton pump inhibitor drugs omeprazole and in its chiral‐switch esomeprazole magnesium was studied employing the Density Functional Theory (DFT) method. At B3LYP/6‐311G(<italic>d</italic>, <italic>p</italic>), the 6‐methoxy∙∙∙6‐methoxy and 5‐methoxy∙∙∙5‐methoxy homochiral and heterochiral dimers were calculated. The chiral distinction free energies (ΔΔ<italic>G</italic><sub><italic>298</italic>, (<italic>RS‐SS</italic>)</sub>) between the cyclic <italic>C</italic><sub>2</sub>‐(<italic>S</italic>, <italic>S</italic>)‐ and <italic>C<sub>i</sub></italic>‐(<italic>R</italic>, <italic>S</italic>)‐dimers with two <named-content content-type="reactionType" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">intermolecular</named-content> hydrogen bonds are 3.8, 1.9 (with BSSE counterpoise correction), and –6.9 (with D3 dispersion and BSSE counterpoise corrections) kJ/mol. Adding water as an implicit solvent (polarized continuum model [PCM] model) resulted in a chiral distinction energy of –3.3 kJ/mol, indicating a reversal of the order of the relative stabilities of <italic>C</italic><sub>2</sub>‐(<italic>S</italic>, <italic>S</italic>)‐ and <italic>C<sub>i</sub></italic>‐(<italic>R</italic>, <italic>S</italic>)‐dimers. The chiral distinction free energies between the corresponding (less stable) <italic>C</italic><sub>1</sub>‐dimers with one <named-content content-type="reactionType"<abstract abstract-type="main"> <title>ABSTRACT</title> <p>Chiral distinction in the proton pump inhibitor drugs omeprazole and in its chiral‐switch esomeprazole magnesium was studied employing the Density Functional Theory (DFT) method. At B3LYP/6‐311G(<italic>d</italic>, <italic>p</italic>), the 6‐methoxy∙∙∙6‐methoxy and 5‐methoxy∙∙∙5‐methoxy homochiral and heterochiral dimers were calculated. The chiral distinction free energies (ΔΔ<italic>G</italic><sub><italic>298</italic>, (<italic>RS‐SS</italic>)</sub>) between the cyclic <italic>C</italic><sub>2</sub>‐(<italic>S</italic>, <italic>S</italic>)‐ and <italic>C<sub>i</sub></italic>‐(<italic>R</italic>, <italic>S</italic>)‐dimers with two <named-content content-type="reactionType" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">intermolecular</named-content> hydrogen bonds are 3.8, 1.9 (with BSSE counterpoise correction), and –6.9 (with D3 dispersion and BSSE counterpoise corrections) kJ/mol. Adding water as an implicit solvent (polarized continuum model [PCM] model) resulted in a chiral distinction energy of –3.3 kJ/mol, indicating a reversal of the order of the relative stabilities of <italic>C</italic><sub>2</sub>‐(<italic>S</italic>, <italic>S</italic>)‐ and <italic>C<sub>i</sub></italic>‐(<italic>R</italic>, <italic>S</italic>)‐dimers. The chiral distinction free energies between the corresponding (less stable) <italic>C</italic><sub>1</sub>‐dimers with one <named-content content-type="reactionType" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">intermolecular</named-content> hydrogen bond are –9.3, –5.8 (with BSSE CC), 17.6 (D3 + BSSE CC), and –3.2 (H<sub>2</sub>O) kJ/mol. The results highlight the contention that omeprazole is not just a superposition of its enantiomer constituents. They are consistent with the pharmacological evidence of enantiomer–enantiomer interactions in omeprazole versus esomeprazole and the differences between the drugs omeprazole and esomeprazole magnesium and support the lodged application for regulatory supplementary protection certificate (SPC) exclusivity for the esomeprazole‐related combination drug Vimovo. <italic>Chirality 26:214–227, 2014.</italic> © 2014 Wiley Periodicals, Inc.</p> </abstract> … (more)
- Is Part Of:
- Chirality. Volume 26:Issue 4(2014:Apr.)
- Journal:
- Chirality
- Issue:
- Volume 26:Issue 4(2014:Apr.)
- Issue Display:
- Volume 26, Issue 4 (2014)
- Year:
- 2014
- Volume:
- 26
- Issue:
- 4
- Issue Sort Value:
- 2014-0026-0004-0000
- Page Start:
- 214
- Page End:
- 227
- Publication Date:
- 2014-03-12
- Subjects:
- Chirality -- Periodicals
Pharmaceutical chemistry -- Periodicals
541.22 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1520-636X ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/chir.22304 ↗
- Languages:
- English
- ISSNs:
- 0899-0042
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3181.124450
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3682.xml